CN1655846A - Pde抑制剂与白三烯受体拮抗剂的并用药物 - Google Patents
Pde抑制剂与白三烯受体拮抗剂的并用药物 Download PDFInfo
- Publication number
- CN1655846A CN1655846A CNA02818260XA CN02818260A CN1655846A CN 1655846 A CN1655846 A CN 1655846A CN A02818260X A CNA02818260X A CN A02818260XA CN 02818260 A CN02818260 A CN 02818260A CN 1655846 A CN1655846 A CN 1655846A
- Authority
- CN
- China
- Prior art keywords
- inn
- phenyl
- active component
- code name
- oxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (26)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01000474.5 | 2001-09-19 | ||
EP01000474 | 2001-09-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1655846A true CN1655846A (zh) | 2005-08-17 |
CN100346831C CN100346831C (zh) | 2007-11-07 |
Family
ID=8176066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB02818260XA Expired - Fee Related CN100346831C (zh) | 2001-09-19 | 2002-09-17 | Pde抑制剂与白三烯受体拮抗剂的并用药物 |
Country Status (26)
Country | Link |
---|---|
US (1) | US20050014762A1 (zh) |
EP (1) | EP1429843B1 (zh) |
JP (1) | JP2005505570A (zh) |
KR (1) | KR20040044946A (zh) |
CN (1) | CN100346831C (zh) |
AT (1) | ATE349243T1 (zh) |
BR (1) | BR0212582A (zh) |
CA (1) | CA2460442A1 (zh) |
CO (1) | CO5560584A2 (zh) |
CY (1) | CY1106365T1 (zh) |
DE (1) | DE60217139T2 (zh) |
DK (1) | DK1429843T3 (zh) |
EA (1) | EA007736B1 (zh) |
ES (1) | ES2279004T3 (zh) |
HK (1) | HK1066752A1 (zh) |
HU (1) | HUP0500078A3 (zh) |
IL (2) | IL160272A0 (zh) |
MA (1) | MA27136A1 (zh) |
MX (1) | MXPA04002560A (zh) |
NO (1) | NO331885B1 (zh) |
NZ (1) | NZ532279A (zh) |
PL (1) | PL205927B1 (zh) |
PT (1) | PT1429843E (zh) |
SI (1) | SI1429843T1 (zh) |
WO (1) | WO2003024488A2 (zh) |
ZA (1) | ZA200402653B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0719518D0 (en) * | 2007-10-05 | 2007-11-14 | Therapeutics Ltd E | Therapy |
RU2470639C2 (ru) * | 2007-10-25 | 2012-12-27 | Мерк Фросст Кэнада Лтд. | Композиции для ингаляции, содержащие кислоту монтелукаст и ингибитор pde-4 или ингаляционный кортикостероид |
WO2012168907A1 (en) * | 2011-06-10 | 2012-12-13 | Glenmark Pharmaceuticals Sa | Pharmaceutical composition comprising revamilast and montelukast or zafirlukast |
WO2014012954A1 (en) | 2012-07-18 | 2014-01-23 | Takeda Gmbh | Treatment of partly controlled or uncontrolled severe asthma |
MD20150071A2 (ro) | 2013-02-19 | 2016-02-29 | Pfizer Inc. | Compuşi azabenzimidazolici ca inhibitori ai PDE4 izoenzimelor pentru tratamentul tulburărilor SNC şi altor afecţiuni |
WO2015063669A1 (en) | 2013-10-30 | 2015-05-07 | Wockhardt Limited | Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof |
JP2017503814A (ja) | 2014-01-22 | 2017-02-02 | タケダ ゲー・エム・ベー・ハーTakeda GmbH | 部分的コントロール状態の重症喘息またはコントロール不良状態の重症喘息のpde4インヒビターを用いた(およびロイコトリエン調節薬と組み合わせて用いた)治療 |
JP6713982B2 (ja) | 2014-07-24 | 2020-06-24 | ファイザー・インク | ピラゾロピリミジン化合物 |
JP6506833B2 (ja) | 2014-08-06 | 2019-04-24 | ファイザー・インク | イミダゾピリダジン化合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR028986A1 (es) * | 1999-02-23 | 2003-06-04 | Smithkline Beecham Corp | USO DE UN INHIBIDOR DE PDE4 EN LA FABRICACIoN DE UNA PREPARACIoN DE LIBERACIoN CONTROLADA; FORMULACION DE LIBERACION CONTROLADA PARA EL TRATAMIENTO DE COPD, UN PROCEDIMIENTO PARA SU PREPARACIoN Y COMPOSICIoN FARMACÉUTICA |
KR100701904B1 (ko) * | 1999-08-21 | 2007-04-02 | 알타나 파마 아게 | Pde 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합 |
MY134008A (en) * | 1999-12-22 | 2007-11-30 | Merck Frosst Canada Inc | Subtituted 8-arylquinoline phospohodiestrase-4 inhibitors |
US7354941B2 (en) * | 2000-01-31 | 2008-04-08 | Pfizer Products Inc. | Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes |
MY123585A (en) * | 2000-03-23 | 2006-05-31 | Merck Canada Inc | Tri-aryl-substituted-ethane pde4 inhibitors. |
EP1289961A1 (en) * | 2000-05-25 | 2003-03-12 | Merck Frosst Canada & Co. | Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor |
-
2002
- 2002-09-17 IL IL16027202A patent/IL160272A0/xx active IP Right Grant
- 2002-09-17 BR BR0212582-0A patent/BR0212582A/pt not_active Application Discontinuation
- 2002-09-17 NZ NZ532279A patent/NZ532279A/en not_active IP Right Cessation
- 2002-09-17 WO PCT/EP2002/010423 patent/WO2003024488A2/en active IP Right Grant
- 2002-09-17 CA CA002460442A patent/CA2460442A1/en not_active Abandoned
- 2002-09-17 MX MXPA04002560A patent/MXPA04002560A/es active IP Right Grant
- 2002-09-17 AT AT02798730T patent/ATE349243T1/de active
- 2002-09-17 JP JP2003528582A patent/JP2005505570A/ja active Pending
- 2002-09-17 EP EP02798730A patent/EP1429843B1/en not_active Expired - Lifetime
- 2002-09-17 DE DE60217139T patent/DE60217139T2/de not_active Expired - Lifetime
- 2002-09-17 DK DK02798730T patent/DK1429843T3/da active
- 2002-09-17 HU HU0500078A patent/HUP0500078A3/hu unknown
- 2002-09-17 CN CNB02818260XA patent/CN100346831C/zh not_active Expired - Fee Related
- 2002-09-17 EA EA200400416A patent/EA007736B1/ru not_active IP Right Cessation
- 2002-09-17 ES ES02798730T patent/ES2279004T3/es not_active Expired - Lifetime
- 2002-09-17 US US10/489,903 patent/US20050014762A1/en not_active Abandoned
- 2002-09-17 KR KR10-2004-7003963A patent/KR20040044946A/ko not_active Application Discontinuation
- 2002-09-17 PT PT02798730T patent/PT1429843E/pt unknown
- 2002-09-17 SI SI200230500T patent/SI1429843T1/sl unknown
- 2002-09-17 PL PL367414A patent/PL205927B1/pl unknown
-
2004
- 2004-02-08 IL IL160272A patent/IL160272A/en not_active IP Right Cessation
- 2004-03-18 MA MA27581A patent/MA27136A1/fr unknown
- 2004-03-24 CO CO04027775A patent/CO5560584A2/es not_active Application Discontinuation
- 2004-04-05 ZA ZA200402653A patent/ZA200402653B/en unknown
- 2004-04-19 NO NO20041595A patent/NO331885B1/no not_active IP Right Cessation
- 2004-12-09 HK HK04109771A patent/HK1066752A1/xx not_active IP Right Cessation
-
2007
- 2007-03-09 CY CY20071100329T patent/CY1106365T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
MA27136A1 (fr) | 2005-01-03 |
BR0212582A (pt) | 2004-10-13 |
DE60217139T2 (de) | 2007-10-04 |
EP1429843A2 (en) | 2004-06-23 |
PL205927B1 (pl) | 2010-06-30 |
ZA200402653B (en) | 2005-02-14 |
HK1066752A1 (en) | 2005-04-01 |
KR20040044946A (ko) | 2004-05-31 |
NZ532279A (en) | 2006-02-24 |
WO2003024488A3 (en) | 2003-09-04 |
EA200400416A1 (ru) | 2004-12-30 |
EP1429843B1 (en) | 2006-12-27 |
JP2005505570A (ja) | 2005-02-24 |
HUP0500078A2 (hu) | 2005-04-28 |
HUP0500078A3 (en) | 2010-07-28 |
PL367414A1 (en) | 2005-02-21 |
NO331885B1 (no) | 2012-04-30 |
IL160272A0 (en) | 2004-07-25 |
DK1429843T3 (da) | 2007-04-30 |
CA2460442A1 (en) | 2003-03-27 |
IL160272A (en) | 2008-03-20 |
US20050014762A1 (en) | 2005-01-20 |
SI1429843T1 (sl) | 2007-06-30 |
EA007736B1 (ru) | 2006-12-29 |
ES2279004T3 (es) | 2007-08-16 |
WO2003024488A2 (en) | 2003-03-27 |
PT1429843E (pt) | 2007-03-30 |
DE60217139D1 (de) | 2007-02-08 |
ATE349243T1 (de) | 2007-01-15 |
MXPA04002560A (es) | 2004-05-31 |
CY1106365T1 (el) | 2011-10-12 |
CN100346831C (zh) | 2007-11-07 |
NO20041595L (no) | 2004-06-16 |
CO5560584A2 (es) | 2005-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1250290C (zh) | 基于抗胆碱能有效的化合物及β-模拟物的新颖药物组合物 | |
CN1155368C (zh) | 鼻腔给药的粉剂组合物 | |
CN1181825C (zh) | 秋水仙醇衍生物在制备作为血管破坏剂的药物中的应用 | |
CN1196488C (zh) | 3-羟基-3-甲基戊二酸单酰辅酶a还原酶抑制剂制造治疗糖尿病性神经病的药物的应用 | |
CN1126533C (zh) | 有机组合物的改进或有关有机组合物的改进 | |
CN1184971C (zh) | 药物组合制剂 | |
CN1960720A (zh) | 肽类化合物治疗肌萎缩性侧索硬化的新用途 | |
CN1960759A (zh) | 含有抗毒蕈碱剂和β-肾上腺素激动剂的组合 | |
CN1615124A (zh) | 配方 | |
CN1155409C (zh) | 用于预防和治疗动脉硬化的药物组合物 | |
CN1086708A (zh) | 具有两阶段释放特征的固体药物及其生产方法 | |
CN100346831C (zh) | Pde抑制剂与白三烯受体拮抗剂的并用药物 | |
CN1308535A (zh) | 供治疗关节病的法呢基(Farnesyl)蛋白质转移酶抑制剂 | |
CN1922150A (zh) | 吲唑衍生物以及含有它们的药物组合物 | |
CN1726028A (zh) | 固体口服剂型药物 | |
CN1762357A (zh) | 一种莫西沙星口服药物制剂及其制备方法 | |
CN100350908C (zh) | 新颖的抗变态反应抗炎组合物 | |
CN1681783A (zh) | 2,4-取代吲哚和它们作为5-ht6调节剂的用途 | |
CN1265838C (zh) | 用于小动物的可注射兽医合成物 | |
CN1170536C (zh) | 四氢苯并[cd]吲哚-6-甲酰胺类化合物在制备用于预防呕吐的药物中的用途 | |
CN1968699A (zh) | 阿昔洛韦制剂 | |
CN1345725A (zh) | 治疗慢性阻塞性肺部疾病的二氮杂䓬并吲哚 | |
CN1265793C (zh) | 左西替利嗪伪麻黄碱复方口服制剂及制备方法 | |
CN1655787A (zh) | 治疗慢性疼痛的三单胺再摄取抑制剂 | |
CN1516586A (zh) | 新型口服全身麻醉剂和抵抗代谢的抗惊厥药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: NICOMEDES LIMITED LIABILITY COMPANY Free format text: FORMER NAME OR ADDRESS: OTANA MEDICINE AG |
|
CP01 | Change in the name or title of a patent holder |
Address after: Konstanz Patentee after: NYCOMED GmbH Address before: Konstanz Patentee before: ALTANA PHARMA AG |
|
C56 | Change in the name or address of the patentee |
Owner name: NYCOMED INC. Free format text: FORMER NAME: NYCOMED GMBH |
|
CP01 | Change in the name or title of a patent holder |
Address after: Konstanz Patentee after: NYCOMED GmbH Address before: Konstanz Patentee before: Nycomed GmbH |
|
C56 | Change in the name or address of the patentee |
Owner name: TAKEDA GMBH Free format text: FORMER NAME: NYCOMED INC. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Konstanz Patentee after: TAKEDA GmbH Address before: Konstanz Patentee before: Nycomed GmbH |
|
ASS | Succession or assignment of patent right |
Owner name: NYCOMED GERMANY HOLDING GMBH Free format text: FORMER OWNER: NYCOMED ASSET MANAGEMENT GMBH Effective date: 20150619 Owner name: NYCOMED ASSET MANAGEMENT GMBH Free format text: FORMER OWNER: TAKEDA GMBH Effective date: 20150619 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: TAKEDA GMBH Free format text: FORMER NAME: NYCOMED GERMANY HOLDING GMBH |
|
CP01 | Change in the name or title of a patent holder |
Address after: Konstanz Patentee after: TAKEDA GmbH Address before: Konstanz Patentee before: Nycomed Germany holding LLC |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150619 Address after: Konstanz Patentee after: Nycomed Germany holding LLC Address before: Konstanz Patentee before: Nycomed asset management LLC Effective date of registration: 20150619 Address after: Konstanz Patentee after: Nycomed asset management LLC Address before: Konstanz Patentee before: TAKEDA GmbH |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071107 Termination date: 20150917 |
|
EXPY | Termination of patent right or utility model |